Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dolphimed A/S
A/S
Active
Advertising protection
CVR 42539023
Pilestræde 58, 1112
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 4 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Dolphimed A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
OJ
Ole Johan Gillebo
Chief Executive Officer
Chief Executive Officer
2023
Former (2)
HL
Henrik Lassen
Management
Management
2021 – 2023
PA
Peter Andreas Stakemann
Management
Management
2021 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
PC
Per Christian Methi
Chairman
Chairman
2023
SK
Spiros Kotopoulis
Board of Directors
Board of Directors
2023
Former (2)
TJ
Thomas Jeffrey Malherbes Gullacksen
Chairman
Chairman
2021 – 2021
UL
Ulf Lund
Board of Directors
Board of Directors
2021 – 2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Asset Segregated SPV #114 IC
Individual
33.33–49.99%
33.33–49.99%
2022
Escala Capital AS
Individual
25–33.32%
25–33.32%
2022
KOMM-IN AS
Individual
5–9.99%
5–9.99%
2022
Dolphitech AS
Individual
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Dolphimed A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network